Citadel Advisors’s EnteroMedics Inc. ETRM Stock Holding History

Citadel Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2	Closed	-$1K	–	9758
2015 Q2	$1K	Sell	2 -8	-80%	-$9.2K	﹤0.01%	8683
2015 Q1	$10K	Buy	+10	New	+$12.1K	﹤0.01%	8205
2014 Q4	–	Sell	-5	Closed	-$6K	–	9151
2014 Q3	$6K	Sell	5 -14	-74%	-$20.5K	﹤0.01%	7901
2014 Q2	$31K	Buy	19 +13	+217%	+$24.3K	﹤0.01%	7072
2014 Q1	$12K	Buy	+6	New	+$14.2K	﹤0.01%	7484

Other funds holding ETRM

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Citadel Advisors's ETRM Position: Q4 2017 in Review

Citadel Advisors sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 16,421 shares — an estimated $29K sold.

Citadel Advisors first reported a position in ETRM in Q3 2013 and held it in 8 quarters. The position peaked at $232K in Q1 2014. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.

Citadel Advisors reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
Citadel Advisors sold 16,421 EnteroMedics Inc. shares in Q4 2017, an estimated $29K.
Citadel Advisors first reported a position in EnteroMedics Inc. in Q3 2013 and held it in 8 quarters.
Citadel Advisors's EnteroMedics Inc. position peaked at $232K in Q1 2014.
1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.